Kenya AIDS Vaccine Initiative

Academic/Hospital

Also known as: KAVI (Kenya AIDS Vaccine Initiative) | Kenya AIDS Vaccine Initiative - Institute of Clinical Research (KAVI-ICR) | Kenya AIDS Vaccine Initiative, Kangemi, Kenya

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Apr 1, 2003

Last known activity

Dec 3, 2018

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 4 trials)

Phase 2 (2 own, 0 via acquisition)

dna.hiva
mva.hiva

Phase 1 (5 own, 0 via acquisition)

ad26.enva.01 vaccine
ad35-env
ad35-grin
ad35 investigational hiv vaccine
bg505 sosip.664 gp140

Indications

Studied for

HIV Infections

Recent trials (5)

NCT03699241CollaboratorPhase 1Dec 3, 2018
NCT03699241Overall official - principal investigatorPhase 1Dec 3, 2018
NCT01264445Overall official - principal investigatorPhase 1Feb 1, 2011
NCT01215149Overall official - principal investigatorPhase 1Oct 1, 2010
NCT01371175Overall official - principal investigatorPhase 2Apr 1, 2003

Details

Last known activity: Dec 3, 2018